Loading clinical trials...
Loading clinical trials...
The primary aim of this study is to examine the effect of acute ingestion of fructose on serum FGF21 levels. Subjects in this study will be lean volunteers and individuals with metabolic syndrome.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beth Israel Deaconess Medical Center
NCT07488468 · Preoperative Fasting, Perioperative Patient Comfort / Quality of Care, and more
NCT07447505 · Glycemic Response; Satiety, Fasting, Time Restricted, and more
NCT06510972 · Respiratory Insufficiency, Fasting, and more
NCT06671613 · Stage IV NSCLC, NSCLC, and more
NCT07216989 · Insulin Resistance, Fasting
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions